Target intelligence / Profile preview

Formin-like protein 3 (FMNL3)

Target
FMNL3
Molecular classification
Cytoskeletal regulator, Actin assembly factor (Formin family protein)
01

Overview

Formin-like protein 3 (FMNL3) is a vertebrate-specific member of the formin family of proteins, which act as actin assembly factors crucial for cytoskeletal remodeling. FMNL3 contains conserved formin homology domains such as FH2, involved in the nucleation and elongation of actin filaments—a process central to forming filopodia, plasma membrane protrusions, and maintaining cell–cell adhesion. Unlike many formins, FMNL3's FH2 domain is a poor nucleator and requires its C-terminus for potent nucleation activity. FMNL3 is heavily localized at the plasma membrane, particularly at filopodia and nascent cell–cell adhesions, and its suppression impairs filopodia formation and cell–cell contacts, affecting collective cell migration. It plays a key role in angiogenesis by regulating endothelial cell elongation and microtubule alignment. FMNL3’s activity is regulated in part by Rho GTPases. Disease associations include impacts on cancer cell migration and vascular development disorders, but specific drug interactions, biomarker status, or known therapeutic safety concerns are not currently documented in the literature.

Other names
Formin-like protein 3FMNL3FRL2KIAA2014DKFZp762B245MGC45819WBP3WW domain-binding protein 3formin homology 2 domain-containing protein 3
02

Biological functions

Actin filament nucleation and elongationFilopodia assemblyCell–cell adhesion regulationPlasma membrane protrusion formationMicrotubule alignment during angiogenesisCell migration
03

Disease associations

Cancer (e.g., cell migration in prostate cancer)Cardiovascular disease/angiogenesis

Beyond the preview

Go deeper on Formin-like protein 3 (FMNL3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Formin-like protein 3 (FMNL3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call